Moelis stock snapshot after recent trading moves

Moelis (MC) recently closed at US$65.76, with the stock up 0.2% on the day and about 5.6% over the past week, while showing a decline of 3.4% over the past month.

Looking beyond this week, the stock’s recent 7 day share price return of 5.6% contrasts with a weaker year to date share price return of 7.7% down. At the same time, a 1 year total shareholder return of 17.2% and 3 year total shareholder return of 93.1% point to stronger gains for investors who have stayed invested over time.

If Moelis’s move has you thinking about other opportunities in finance related services, it could be a good moment to scan a wider field of companies through the 20 top founder-led companies

With Moelis trading at US$65.76 and data pointing to an estimated intrinsic value gap of about 28%, the key question is whether this signals an undervalued advisory specialist or whether the market is already pricing in future growth.

Most Popular Narrative: 14% Undervalued

Moelis’s most followed narrative points to a fair value of about $76.50, comfortably above the last close at $65.76, which is what anchors the current upside case.

The analysts have a consensus price target of $78.6 for Moelis based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $90.0, and the most bearish reporting a price target of just $65.0.

Want to see what sits behind that valuation gap? The narrative ties together higher earnings, wider margins and a richer future profit multiple. The exact assumptions may surprise you.

Using an 8.22% discount rate, the narrative values Moelis by projecting future revenues, profits and share count, then bringing those cash flows back to today’s dollars.

It links that fair value to expectations that earnings and revenue continue to grow, margins stay healthy and the stock trades on a P/E that is lower than the current industry average but still reflects strong profitability.

Result: Fair Value of $76.50 (UNDERVALUED)

However, this hinges on Moelis turning investment in new bankers and private capital advisory into sustained deal fees, while avoiding margin pressure from higher compensation and compliance costs.

Another lens on Moelis’s value

While the earlier narrative leans on detailed cash flow projections, the market is currently paying a P/E of 22.1x for Moelis, compared with an estimated fair ratio of 14.9x, its Capital Markets industry at 40.1x and peers at 21x. That mix of “expensive” versus fair ratio but cheaper than industry raises a simple question: is the risk skewed toward multiple compression or a move toward the fair ratio?

Next Steps

Mixed messages in the data so far? If that leaves you on the fence, act now by weighing up the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop with just one stock, you could miss other opportunities that better fit your goals, so keep your options open and compare a few standouts.

• Spot potential bargains by scanning 48 high quality undervalued stocks that pair quality fundamentals with share prices that sit below their estimated worth.
• Strengthen the income side of your portfolio by reviewing 10 dividend fortresses that focus on higher yielding companies.
• Prioritise resilience by checking 65 resilient stocks with low risk scores that highlight businesses with lower overall risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.